Advertisement

Analgesic Therapy in Acute Myocardial Infarction

  • Author Footnotes
    * Assistant Professor of Medicine, Yale University School of Medicine; and Attending Physician, Yale-New Haven Hospital, New Haven, and West Haven VA Medical Center, West Haven, Connecticut
    Michael S. Remetz
    Correspondence
    Corresponding Author: Section of Cardiology, 3 FMP Yale University School of Medicine 333 Cedar Street P.O. Box 3333 New Haven, CT 06510
    Footnotes
    * Assistant Professor of Medicine, Yale University School of Medicine; and Attending Physician, Yale-New Haven Hospital, New Haven, and West Haven VA Medical Center, West Haven, Connecticut
    Search for articles by this author
  • Author Footnotes
    † Associate Professor of Medicine and Pathology, Yale University School of Medicin e; Director of the Coronary Care Unit; and Associate Director of the Cardiac Catheterization Laboratory, Yale-New Haven Hospital, New Haven, Connecticut
    Henry S. Cabin
    Footnotes
    † Associate Professor of Medicine and Pathology, Yale University School of Medicin e; Director of the Coronary Care Unit; and Associate Director of the Cardiac Catheterization Laboratory, Yale-New Haven Hospital, New Haven, Connecticut
    Search for articles by this author
  • Author Footnotes
    * Assistant Professor of Medicine, Yale University School of Medicine; and Attending Physician, Yale-New Haven Hospital, New Haven, and West Haven VA Medical Center, West Haven, Connecticut
    † Associate Professor of Medicine and Pathology, Yale University School of Medicin e; Director of the Coronary Care Unit; and Associate Director of the Cardiac Catheterization Laboratory, Yale-New Haven Hospital, New Haven, Connecticut
      This paper is only available as a PDF. To read, Please Download here.
      Adequate analgesic therapy for patients with acute myocardial ischemic syndromes is a critical facet of patient management. By knowing the different pharmacologic properties of various narcotic drugs, a proper choice can be made matching the appropriate analgesic agent’s side effect profile with an individual patient’s hemodynamic status.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alderman D.L.
        • Barry W.H.
        • Graham A.F.
        • et al.
        Hemodynamic effects of morphine and pentazocine differ in cardiac patients.
        N Engl J Med. 1972; 287: 623-627
        • Beaver W.T.
        • Feise G.A.
        A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain.
        J Pharmacol Exp Ther. 1978; 204: 487-496
        • Christie G.
        • Gershon S.
        • Gray R.
        • et al.
        Treatment of certain side effects of morphine.
        Br Med J. 1958; 1: 675-680
        • Drew J.H.
        • Dripps R.D.
        • Comroe J.H.
        Clinical studies on morphine. II. The effect of morphine upon the circulation of man and upon the circulatory and respiratory responses to tilting.
        Anesthesiology. 1946; 7: 44-61
        • Eckenhoff J.E.
        • Oech S.R.
        The effects of narcotics and antagonists upon respiration and circulation in man: A review.
        Clin Pharmacol Ther. 1960; 1: 483-524
        • Errick J.K.
        • Heel R.C.
        Nalbuphine: A preliminary review of its pharmacological properties and therapeutic efficacy.
        Drugs. 1983; 26: 191-211
        • Harvey W.P.
        • Berkman F.
        • Leonard J.
        Caution against the use of meperidine hydrochloride in patients with heart disease, particularly auricular flutter.
        Am Heart J. 1955; 49: 758-769
        • Henney R.P.
        • Vasko J.S.
        • Brawley R.K.
        • et al.
        The effects of morphine on the resistance and capacitance vessels of the peripheral circulation.
        Am Heart J. 1966; 72: 242-250
        • Herrick J.
        Clinical features of sudden obstruction of the coronary arteries.
        JAMA. 1912; 59: 2015-2020
        • Hoel B.L.
        • Refsum H.E.
        The effect of morphine on arterial blood gases in patients with acute myocardial infarction.
        Acta Med Scand. 1969; 186: 511-513
        • Jasinski D.R.
        • Mansky P.A.
        Evaluation of nalbuphine for abuse potential.
        Clin Pharmacol Ther. 1972; 13: 78-90
        • Kalant H.
        • Roschlau W.H.E.
        • Sellers E.M.
        Principles of Medical Pharmacology.
        Oxford University Press, New York1985: 251-263
        • Kerr F.
        • Donald K.W.
        Analgesia in myocardial infarction.
        Br Heart J. 1974; 36: 117-121
        • Kerr F.
        • Ewing D.J.
        • Irving J.B.
        • et al.
        Nitrous-oxide analgesia in myocardial infarction.
        Lancet. 1972; 1: 62-66
        • Krueger H.
        • Eddy N.B.
        • Sum wait M.
        The pharmacology of the opium alkaloids.
        Public Health Rep. 1941;
        • Lake C.L.
        • Duckworth E.N.
        • DiFazio C.A.
        • et al.
        Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease.
        Anesthesiology. 1982; 57: 498-503
        • Lai S.
        • Savidge R.D.
        • Chhabra G.P.
        Cardiovascular and respiratory effects of morphine and pentazocine in patients with myocardial infarction.
        Lancet. 1969; 1: 379-381
        • Lappas D.G.
        • Geha D.
        • Fischer J.E.
        • et al.
        Filling pressures of the heart and pulmonary circulation of the patient with coronary artery disease after large doses of morphine.
        Anesthesiology. 1975; 42: 153-159
        • Lee G.
        • DeMaria A.N.
        • Amsterdam E.A.
        • et al.
        Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction.
        Am J Med. 1976; 60: 949-955
        • Lee G.
        • Low R.I.
        • Amsterdam E.A.
        • et al.
        Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction.
        Clin Pharmacol Ther. 1981; 29: 576-581
        • Lewis J.R.
        Evaluation of new analgesics: Butorphanol and nalbuphine.
        JAMA. 1980; 243: 1465-1467
        • Lowenstein E.
        • Hallowell P.
        • Levine F.H.
        • et al.
        Cardiovascular response to large doses of intravenous morphine in man.
        N Engl J Med. 1969; 281: 1389-1393
        • Miller R.R.
        Evaluation of nalbuphine hydrochloride.
        Am J Hosp Pharm. 1980; 37: 942-949
        • Osier W.
        The Principles and Practice of Medicine.
        D Appleton, New York1892: 626
        • Rang H.P.
        • Dale M.M.
        Pharmacology.
        Churchill Livingstone, New York1987: 547-567
        • Remetz M.S.
        • Clubb K.S.
        • Merrill S.
        • et al.
        Divergent effects of nalbuphine and morphine in patients with unstable angina or acute myocardial infarction.
        Clin Res. 1987; 35: 318A
        • Rendig S.V.
        • Amsterdam E.A.
        • Henderson G.L.
        • et al.
        Comparative cardiac contractile actions of six narcotic analgesics: Morphine, meperidine, pentazocine, fen-tanyl, methadone and 1-α-acetylmethadol (LAAM).
        J Pharmacol Exp Ther. 1980; 215: 259-265
        • Romagnoli A.
        • Keats A.S.
        Ceiling effect for respiratory depression by nalbuphine.
        Clin Pharmacol Ther. 1980; 27: 478-485
        • Scott M.E.
        • Orr R.
        Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute myocardial infarction.
        Lancet. 1969; 1: 1065-1069
        • Tammisto T.
        • Jaattela A.
        • Nikki P.
        • et al.
        Effect of pentazocine and pethidine on plasma catecholamine levels.
        Ann Clin Res. 1971; 3: 22-29
        • Tammisto T.
        • Tigerstedt I.
        Comparison of the analgesic effects of intravenous nalbuphine and pentazocine in patients with postoperative pain.
        Acta Anaesthesiol Scand. 1977; 21: 390-394
        • Thomas M.
        • Malmcrona R.
        • Fillmore S.
        • et al.
        Hemodynamic effects of morphine in patients with acute myocardial infarction.
        Br Heart J. 1965; 27: 863-875
        • Thompson P.L.
        • Lown B.
        Nitrous oxide as an analgesic in acute myocardial infarction.
        JAMA. 1976; 235: 924-927
        • Todres D.
        The role of morphine in acute myocardial infarction.
        Am Heart J. 1971; 81: 566-570
        • Van Arman C.G.
        • Sturtevant F.M.
        Release of histamine by meperidine.
        Fed Proc. 1958; 17: 416
        • Vasko J.S.
        • Henney R.P.
        • Brawley R.K.
        • et al.
        Effects of morphine on ventricular function and myocardial contractile force.
        Am J Physiol. 1966; 210: 329-334
        • Vasko J.S.
        • Henney R.P.
        • Oldham H.N.
        • et al.
        Mechanisms of action of morphine in the treatment of experimental pulmonary edema.
        Am J Cardiol. 1966; 18: 876-883
        • Ward J.M.
        • McGrath R.L.
        • Weil J.V.
        Effects of morphine on the peripheral vascular response to sympathetic stimulation.
        Am J Cardiol. 1972; 29: 659-666
        • Zelis R.
        • Mansour E.J.
        • Capone R.J.
        • et al.
        The cardiovascular effects of morphine on the peripheral capacitance and resistance vessels in human subjects.
        J Clin Invest. 1974; 54: 1247-1258